Alam Kamran (CIK 1793412) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-06). Recent activity: Sell TSHA (1,655 shares), Sell TSHA (78,968 shares), Sell TSHA (23,849 shares), Buy TSHA (359,000 shares), Sell TSHA (54,491 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-06 | Taysha Gene Therapies, Inc. (TSHA) | CHIEF FINANCIAL OFFICER | Sell | 1,655 | $7,481 |
| 2026-01-27 | Taysha Gene Therapies, Inc. (TSHA) | CHIEF FINANCIAL OFFICER | Sell | 78,968 | $375,098 |
| 2026-01-27 | Taysha Gene Therapies, Inc. (TSHA) | CHIEF FINANCIAL OFFICER | Sell | 23,849 | $109,944 |
| 2026-01-14 | Taysha Gene Therapies, Inc. (TSHA) | CHIEF FINANCIAL OFFICER | Buy | 359,000 | $0 |
| 2025-08-22 | Taysha Gene Therapies, Inc. (TSHA) | CHIEF FINANCIAL OFFICER | Sell | 54,491 | $155,299 |
| 2025-03-13 | Taysha Gene Therapies, Inc. (TSHA) | CHIEF FINANCIAL OFFICER | Sell | 29,843 | $50,435 |
Source: SEC Form 4 filings · as of 2026-02-06